Abstract:
The present invention provides a novel sirtuin-1 activating agent, and a formulation for suppressing cell senescence caused by oxidative stress, comprising the agent.In particular, the invention provides a sirtuin-1 activating agent consisting of a plant body or solvent extract of Peucedanum japonicum Thunb., and a formulation for suppressing cell senescence due to oxidative stress, comprising the agent.
Abstract:
An objective of the present invention is to provide a solid powder cosmetic excellent in impact resistance and usability despite that boron nitride and spherical resin particle are blended in a large amount. The present invention provides a solid powder cosmetic comprising: 12-30 mass % of synthetic fluorphlogopite iron; 5-15 mass % of boron nitride; and 5-15 mass % of phenyl-modified silicone spherical elastic powder.
Abstract:
The present invention addresses the problem of identifying a biomarker of renal failure, said biomarker being available from urine or blood, and fluctuating from an early stage than glomerular filtration rate and serum creatinine level, and thus developing a technique for diagnosing early stage kidney failure. A method for analyzing the blood, plasma, serum or urine of a renal failure suspected subject comprises a step of measuring the concentration of a pair of D-form and L-form of at least one amino acid selected from the amino acid group consisting of [D-serine] and [L-serine], etc., contained in the blood, plasma, serum or urine of the subject, and calculating, as an pathological index of the subject, the ratio of the D-form concentration to the L-form concentration or the percentage of the D-form concentration relative to the total concentration of the D-form and L-form.
Abstract:
An aqueous skin cosmetic product exerting a high irregularity correction effect, providing a non-greasy and light feeling when applied and having an excellent sebum suppressing effect is provided. The skin cosmetic product of the present invention is characterized by comprising (A) 15 to 50% by mass of a powder formed of an (adipic acid/neopentyl glycol) crosspolymer and (B) 0.5 to 3% by mass of a hydrophobically modified polyurethane. (PEG-240/Decyltetradeceth-20/HDI) copolymer is preferable as the hydrophobically modified polyurethane, It is preferable that the skin cosmetic product is a gel having a viscosity of 15,000 mPa·s or more and 200,000 mPa·s or less.
Abstract:
The present invention is directed to an extrace of Psilotum spp., as a skin whitening agent. Whitening agents according to the invention exhibit superior effects, for example, by lightening and whitening skin pigmentation, lightening and whitening aging spots, freckles, chloasma, or the like after sunburn. The Psilotum spp. extract of the invention has a superior free radical scavenging ability permitting the extract to control skin aging and skin diseases caused by active oxygen (free radicals), while having a high level of safety.
Abstract:
An image analysis apparatus that analyzes a skin condition from a video of the face of a subject captured with an imaging part includes a tracking part configured to track the amount of changes of multiple tracking points arranged in advance in an analysis region of the face based on a change in the expression of the face included in the video, and obtain the compression ratio of the skin in the analysis region based on the amount of changes, and a skin condition analysis part configured to analyze the skin condition of the subject based on the compression ratio obtained by the tracking part.
Abstract:
The present invention provides an aqueous composition in which vesicles and oil drops are stably coexistent.The aqueous composition of the present invention is characterized by containing (a) an amphiphilic compound, (b) water, and (c) oil, wherein vesicles formed with component (a) and oil drops containing component (c) are present in component (b).
Abstract:
A skin dullness evaluation apparatus includes a frequency analyzing unit that decomposes a skin image into color heterogeneity of a predetermined size; a color heterogeneity index obtaining unit that obtains color data of skin from each of the color heterogeneity decomposed by the frequency analyzing unit, and obtains a color heterogeneity index of the color heterogeneity from the obtained color data of skin; and a dullness evaluation unit that evaluates skin dullness corresponding to the skin image based on the color heterogeneity index obtained by the color heterogeneity index obtaining unit.